Stock Price Movement and Market Context
On 29 Dec 2025, Entero Healthcare Solutions Ltd’s share price touched Rs.944, its lowest level in the past year and an all-time low. This decline comes after two consecutive days of losses, with the stock falling by 1.96% over this period. The day’s trading saw a further dip of 0.52%, underperforming its sector by 0.25%. Notably, the stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward momentum.
In contrast, the broader market index, Sensex, opened flat but moved into negative territory, trading at 84,918.54 points, down 0.14% or 36.70 points. The Sensex remains close to its 52-week high of 86,159.02, just 1.46% away, and is supported by bullish moving averages, with the 50-day moving average positioned above the 200-day moving average. This divergence highlights the relative weakness of Entero Healthcare Solutions Ltd compared to the overall market.
Long-Term and Recent Performance Metrics
Over the past year, Entero Healthcare Solutions Ltd has delivered a total return of -33.38%, significantly lagging behind the Sensex’s positive 7.87% return for the same period. The stock’s 52-week high was Rs.1,564.95, indicating a steep decline of nearly 40% from that peak to the current low. This underperformance extends beyond the last year, with the company also trailing the BSE500 index over the last three years, one year, and three months.
Financial Health and Operational Highlights
Despite the stock’s price weakness, Entero Healthcare Solutions Ltd exhibits some positive financial attributes. The company maintains a low Debt to EBITDA ratio of 1.33 times, reflecting a strong capacity to service its debt obligations. This conservative leverage profile is a stabilising factor amid market volatility.
On the growth front, the company has demonstrated robust long-term expansion, with net sales increasing at an annual rate of 30.10%. Operating profit has surged even more impressively, growing by 127.38% annually. The latest quarterly results reinforce this trend, with net sales reaching a record Rs.1,570.95 crore and PBDIT hitting Rs.62.06 crore, the highest quarterly figures reported by the company. The operating profit margin to net sales also peaked at 3.95% in the most recent quarter.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Valuation and Profitability Indicators
Entero Healthcare Solutions Ltd’s return on capital employed (ROCE) stands at 8.6%, which, combined with an enterprise value to capital employed ratio of 2.2, suggests a very attractive valuation relative to its capital base. The stock currently trades at a discount compared to the average historical valuations of its peers in the retailing sector.
Interestingly, while the stock price has declined by over 33% in the past year, the company’s profits have increased by 142% during the same period. This disparity is reflected in a low PEG ratio of 0.3, indicating that earnings growth has outpaced the stock price movement.
Shareholding and Market Sentiment
Institutional investors hold a significant stake in Entero Healthcare Solutions Ltd, accounting for 24.32% of the share capital. These investors typically possess greater resources and analytical capabilities to assess company fundamentals, which may influence the stock’s trading dynamics.
Why settle for Entero Healthcare Solutions Ltd? SwitchER evaluates this Retailing small-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Recent Rating and Market Assessment
MarketsMOJO has downgraded Entero Healthcare Solutions Ltd from a Hold to a Sell rating as of 15 Nov 2025, reflecting concerns over the company’s below-par performance in both the near and long term. The current Mojo Score stands at 46.0, with a Mojo Grade of Sell, indicating a cautious stance on the stock’s outlook based on quantitative and qualitative factors.
The company’s market capitalisation grade is rated at 3, suggesting a mid-tier market cap within its sector. The downgrade from Hold to Sell underscores the challenges faced by the stock despite its underlying financial strengths.
Summary of Key Price and Performance Data
To summarise, Entero Healthcare Solutions Ltd’s stock price has declined from a 52-week high of Rs.1,564.95 to a new low of Rs.944, representing a significant correction. The stock’s underperformance relative to the Sensex and its sector peers is evident in its negative returns and trading below all major moving averages. While the company’s financial metrics such as sales growth, profitability, and debt servicing capacity remain robust, these have not translated into positive price momentum in the recent period.
Market Environment and Sector Comparison
The retailing sector, in which Entero Healthcare Solutions Ltd operates, has experienced mixed performance, with some stocks maintaining strength while others face headwinds. The Sensex’s proximity to its 52-week high and its bullish technical indicators contrast with the stock’s downward trajectory, highlighting the divergence within the sector and the broader market.
Conclusion
Entero Healthcare Solutions Ltd’s fall to its 52-week low of Rs.944 marks a notable event in its price history, reflecting a period of subdued market sentiment despite solid underlying financial results. The stock’s current valuation metrics and institutional shareholding suggest a complex interplay of factors influencing its market performance.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
